U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award
News Feb 21, 2006
U.S. Genomics has announced that Dr. James A. Spudich of Stanford University is the recipient of the Company's first annual award for Outstanding Investigator Single Molecule Biology Award.
The award will be presented at the 50th Annual Meeting of the Biophysical Society in Salt Lake City, Utah.
The Biophysical Society Awards Program honors its members by recognizing excellence in biophysics and promoting interaction among life scientists throughout the world.
"Biology happens at the molecular level. Dr. Spudich's research achievements with myosin demonstrate the importance of working at the level of single molecules to discover the basis of fundamental cellular processes," said John J. Canepa, CEO of U.S. Genomics.
"As the pioneer of single molecule biology tools, U.S. Genomics is proud to sponsor an award that recognizes and promotes outstanding contributions in this field. The Biophysical Society Annual Meeting offers a premier venue in which to acknowledge Dr. Spudich's great achievements."
"The Biophysical Society is pleased to recognize Dr. Spudich's longstanding efforts to further the study of the molecular basis of cell motility through single molecule approaches," said Steven M. Block, President of the Biophysical Society.
"U.S. Genomics' award will encourage future exploration and acknowledge excellence in this advanced area of biophysics research."
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018